Home > Insider Trading > Filing (0001752836-20-000028)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1752836	Covetrus Inc.	CVET	Retail-Drug Stores And Proprietary Stores (5912)	831448706

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1765583	Jr. C. Anthony Providenti	7 Custom House Street Portland ME 04101	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-02-07	333	$13.00	0	No	4	S	Indirect	By 401(k) Plan

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By 401(k) Plan

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,647	Direct

Footnotes

The Reporting Person is a former employee of Henry Schein, Inc. As a result of Henry Schein, Inc.'s spinoff transaction resulting in Covetrus, Inc. being an independent public company, participants in the Henry Schein 401(k) Savings Plan (the "Henry Schein Plan") who held units in the Henry Schein stock fund as of February 7, 2019 (closing date of the spinoff transaction) were credited with 0.4 of a unit in the Covetrus stock fund for every one unit held of the Henry Schein stock fund. On February 7, 2020, the Covetrus stock fund was removed as an investment option offered through the Henry Schein Plan. Any amounts invested in the Covetrus stock fund as of February 7, 2020 were automatically sold with no investment decision exercised by the holder. This Form 4 reports that automatic sale.
The number of shares sold reflects the Reporting Person's interest in equivalent shares of Covetrus common stock held by the unitized stock fund in the Henry Schein Plan. The unitized stock fund consists of Covetrus common stock and cash or cash equivalents. The number of shares attributed to the Reporting Person as a participant in the Henry Schein Plan and expressed as equivalent shares has been calculated based on the closing price of Covetrus common stock on the date of the reported transaction.